Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19
| Autor: | Abdul Mannan Baig, Erin C. Sanders |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19) Isolation (health care) Physiology viruses Cognitive Neuroscience Pneumonia Viral Psychological intervention Anosmia Disease Dysgeusia Biochemistry Betacoronavirus Olfaction Disorders 03 medical and health sciences 0302 clinical medicine Cerebrospinal fluid Pandemic medicine Humans Respiratory system Intensive care medicine Pandemics 030304 developmental biology Respiratory Distress Syndrome 0303 health sciences SARS-CoV-2 business.industry fungi Brain COVID-19 virus diseases Cell Biology General Medicine Ethmoid Bone Viral Tropism Nervous System Diseases medicine.symptom Coronavirus Infections business 030217 neurology & neurosurgery |
| Zdroj: | ACS Chemical Neuroscience |
| ISSN: | 1948-7193 |
| DOI: | 10.1021/acschemneuro.0c00286 |
| Popis: | The 2019 novel coronavirus disease (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a zoonotic disease that is dominated by pulmonary symptoms. However, recent reports of isolation of the virus from cerebrospinal fluid (CSF) coupled with radiological evidence of zones of necrosis in the brain, have elucidated the neurotropic potential of SARS-CoV-2. The acute respiratory failure seen in patients with COVID-19 is alarming and could be due to the effects of SARS-CoV-2 on the central respiratory regulatory centers in the brainstem. Appropriate interventions can be implemented to prevent severe outcomes of neurological invasion by SARS-CoV-2 to reduce the morbidity and mortality of patients with COVID-19. It is of paramount importance that the scientific community alerts the healthcare professionals of the pieces of evidence that can herald them on the covert neurological deficits in progress in COVID-19. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|